Asthma is a common disease which affects at least 2% of the British population (Gregg, 1977) . The last two decades have seen major advances in safe treatment with regular inhalation of sodium cromoglycate, selective beta2 stimulant drugs (salbutamol, terbutaline etc.) or beclomethasone. For the majority of asthmatics, these drugs can achieve excellent control and allow the patient to lead a normal life even if treatment with oral corticosteroids is also required. It is therefore depressing to note that there is, as yet, little evidence of a significant improvement in asthma mortality. A recent survey (British Thoracic Association, 1982) reported a mortality rate of 1-84 per 100,000, which indicates no real improvement on rates of 0A46-1-34 per 100,000 reported over the last century by Speizer and Doll (1968) . Several recent studies of asthma mortality (Cochrane and Clark, 1975; Ormerod and Stableforth, 1980; British Thoracic Association, 1982) have highlighted two consistent problems; failure to diagnose and assess the severity of asthma by using simple respiratory function tests and, as a result, failure to implement adequate treatment. In this article, I would like to remind the reader of some of the more important pitfalls in the diagnosis of asthma.
Asthma can mimic other respiratory or even cardiac diseases and a common failing is to omit it from the differential diagnosis in patients who do not have the classical and commonest presentation with childhood onset associated with wheezing on exposure to common inhaled allergens such as house dust and grass pollen. (Webb, Clark and Chilver, 1981) .
There has recently been a considerable interest in the phenomenom of nocturnal or early morning asthma (Editorial, 1981a) . This apparently relates to a normal circadian rhythm in airway calibre which is exaggerated by the asthmatic's labile airways. Nocturnal cough and wheezing should alert the clinician to the diagnosis of asthma and it has long been known that asthma attacks can occur almost exclusively at night in some patients (Floyer, 1698) . It is important to realise that in these patients, physical examination and respiratory function tests can be normal during the day when seen in the out-patients or surgery, but every night they may display a deterioration in respiratory function tests compatible with an acute asthma attack (Hetzel, Clark and Houston, 1977 While most cases of extrinsic asthma provoked by common inhaled allergens, such as house dust and pollens, are easily recognised from the history, an increasingly important problem is now being posed by occupational asthma. Apparent late onset intrinsic asthma, or recurrence in adult life after childhood asthma, may be due to agents inhaled at work and a careful occupational history is very important. This is becoming increasingly difficult for the clinician since the range of products and processes which cause occupational asthma is increasing. Moreover, the asthma may be caused, not by the patient's work, but by aerosols generated by his workmates or even exhaust ventilation from another factory across the street which just happens to blow into the patient's work area. Some agents, notably toluene di-isocyanate which is produced in manufacture of polyurethanes and plastics, can cause a severe progressive asthma in non-atopic subjects without a previous history of asthma. Patients may become extremely sensitive to very low concentrations and irreversible airways obstruction may result if the diagnosis is not made early enough and exposure is allowed to continue. Occupational asthma is now a prescribed disease under the Social Security Act (1975) in Britain and compensation can be given, through the Pneumoconiosis Panel, for asthma due to platinum salts, isocyanates, epoxy resins, colophony fumes (in solder fluxes), proteolytic enzymes, laboratory animals and grain or flour dust (Editorial, 198 lb) . Diagnosis tends to become more difficult the longer that the patient's occupational asthma has been present. In the early stages it may be clear that attacks occur while the patient is at work, or on coming home from work. As Failure to take such measurements is a major, correctable, factor in asthma mortality (Cochrane and Clark, 1975) (Rubinfeld and Pain, 1976) . With the introduction of the cheap mini-peak flow meter (Wright, 1978) (Hetzel and Clark, 1980) . Severe morning dips may be ar indicator of a dangerous degree of bronchial labilit3
Pitfalls in the diagnosis of asthma and risk of sudden death (Hetzel, Clark and Branthwaite, 1977; Bateman and Clark, 1979) .
The 'brittle' asthmatic shows a chaotic pattern of PEFR with sudden rapid falls which, nevertheless, may respond rapidly to aerosol bronchodilator drugs but cannot easily be prevented by regular treatment with other conventional drug therapy on a regular basis. These patients also appear to be a high risk group. They may be wrongly accused of aerosol abuse when in fact they have a genuine need to take frequent doses of beta2 stimulant aerosols and may improve if these are taken regularly every few hours. The 'drifter' shows low PEFR readings which at first do not appear to improve, but, as treatment continues a slowly increasing trend can be identified. These patients will not make a dramatic improvement and PEFR may only improve by 100 litre/min or so, but the symptomatic benefit to the patient may still be considerable. In this situation, identification of the slow improvement by PEFR monitoring avoids the common error of abandoning attempts at aggressive treatment too soon.
Patients are occasionally seen who have obvious symptomatic improvement on treatment but in whom the PEFR does not improve. In these cases, more detailed physiological testing is needed to confirm improvement, when it will usually be found that the vital capacity has improved and the functional residual capacity (FRC) has reduced. To understand this phenomenon, noted in acute asthma as the 'guy rope' effect by Woolcock and Read (1966) , it must be remembered that the main driving force in expelling air from the lungs in expiration is the elastic recoil pressure of the lung. To overcome a high airways resistance, patients therefore breathe at a higher FRC so that tidal breathing takes place at a higher point on the compliance curve of the lung; in other words, if the lung interstitium is regarded as a spring, this manoeuvre stretches it so that more force is available when it is released on expiration. Because the compliance curve of the lung is sigmoid in shape, however, greater changes in intrapleural pressure are required for a given change in lung volume so that the work of breathing increases at a high FRC. Thus patients in this category may not achieve a better PEFR when their airways obstruction improves but they can now achieve the same result at a more normal FRC and therefore feel less breathless.
Less commonly, errors are made in diagnosing asthma when this is not the cause of patients' breathlessness. The most serious of these is the misdiagnosis of upper airways obstruction due to tumours, as illustrated in this volume (Parrish, Banks and Fennerty, 1983) (Empey, 1972) . It is best detected, however, by spirometric tests in inspiration, as seen in the inspiratory part of the flow volume loop (Bass, 1973) . The peak inspiratory flow rate is particularly reduced and the loop assumes a characteristic 'box' shape with impairment of both inspiratory and expiratory flow but with more marked impairment of the inspiratory curve.
In conclusion therefore, pitfalls in the diagnosis of asthma are best avoided by an awareness of the range of presentations that are possible and by the use of simple physiological tests, rather than relying on clinical judgement alone. Asthmatics should test PEFR at home just as diabetics test their urine (Editorial, 1978) and it is regrettable that peak flow meters are not available on NHS prescription. The wider use of peak flow meters would enable patients to anticipate deterioration in their asthma so that earlier remedial treatment, with reduced need for outpatient and inpatient treatment, would be possible.
It is a sobering thought that, in a recent study of asthma deaths outside hospital (MacDonald, Seaton and Williams, 1976) , 23% of these fatal attacks lasted less than 30 min so that death frequently occurred before any doctor was available to see patients. For 9 of 21 patients seen by the GP, admission to hospital was not advised, emphasising the difficulty experienced in identifying potentially fatal asthma attacks. This is, of course, the greatest pitfall of all. Peak flow monitoring may not be the complete answer, but it is certainly a significant step in the right direction.
